Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Cholangiocarcinoma 2Rectal Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Bile Duct Neoplasms 1Adrenocortical Carcinoma 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1

Interventions

Capecitabine 22Oxaliplatin 19Fluorouracil 16Radiotherapy 11Leucovorin 10Cetuximab 9Nivolumab 7Bevacizumab 6sintilimab 5Specimen Handling 5Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4pembrolizumab 4Surgical Procedures, Operative 4encorafenib 3X-Rays 3Trastuzumab 3Surveys and Questionnaires 3Sigmoidoscopy 3Radiation 3Pemetrexed 3Gemcitabine 3Endoscopy 3Control Groups 3Consolidation Chemotherapy 3Cisplatin 3Carboplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Floxuridine × 90 days × Clear all
NCT00492999 2026-06-03

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
64 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡